0000899866-14-000168.txt : 20140730 0000899866-14-000168.hdr.sgml : 20140730 20140730170856 ACCESSION NUMBER: 0000899866-14-000168 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140728 FILED AS OF DATE: 20140730 DATE AS OF CHANGE: 20140730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 BUSINESS PHONE: 2037761790 MAIL ADDRESS: STREET 1: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELL LEONARD CENTRAL INDEX KEY: 0001231949 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 141003574 MAIL ADDRESS: STREET 1: C/O ALEXION PHARMACEUTICALS INC STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 wf-form4_140675452469590.xml FORM 4 X0306 4 2014-07-28 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001231949 BELL LEONARD C/O ALEXION PHARMACEUTICALS INC 352 KNOTTER DRIVE CHESHIRE CT 06410 1 1 0 0 CEO Common Stock, par value $.0001 per share 2014-07-28 4 M 0 105600 17.65 A 1137931 D Common Stock, par value $.0001 per share 2014-07-28 4 S 0 9348 160.93 D 1128583 D Common Stock, par value $.0001 per share 2014-07-28 4 S 0 50737 162.01 D 1077846 D Common Stock, par value $.0001 per share 2014-07-28 4 S 0 34768 162.76 D 1043078 D Common Stock, par value $.0001 per share 2014-07-28 4 S 0 8747 163.81 D 1034331 D Common Stock, par value $.0001 per share 2014-07-28 4 S 0 1000 164.72 D 1033331 D Common Stock, par value $.0001 per share 2014-07-28 4 S 0 1000 166.12 D 1032331 D Common Stock, par value $.0001 per share 2014-07-29 4 M 0 1200 17.65 A 1033531 D Common Stock, par value $.0001 per share 2014-07-29 4 S 0 1200 164.93 D 1032331 D Common Stock, par value $.0001 per share 2014-07-30 4 M 0 20489 17.65 A 1052820 D Common Stock, par value $.0001 per share 2014-07-30 4 S 0 13679 165.18 D 1039141 D Common Stock, par value $.0001 per share 2014-07-30 4 S 0 4010 166.42 D 1035131 D Common Stock, par value $.0001 per share 2014-07-30 4 S 0 2800 167.14 D 1032331 D Option to Purchase Common Stock 17.65 2014-07-28 4 M 0 105600 17.65 D 2008-04-09 2018-01-09 Common Stock 105600.0 228736 D Option to Purchase Common Stock 17.65 2014-07-29 4 M 0 1200 17.65 D 2008-04-09 2018-01-09 Common Stock 1200.0 227536 D Option to Purchase Common Stock 17.65 2014-07-30 4 M 0 20489 17.65 D 2008-04-09 2018-01-09 Common Stock 20489.0 207047 D The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $160.42 - $161.42. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $161.42 - $162.42. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $162.42 - $163.42. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $163.43 - $164.43. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $164.44 - $165.44. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $165.84 - $166.84. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $164.90 - $165.90. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $166.91 - $167.91. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $166.98 - $167.98. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Michael Greco Attorney-in-Fact 2014-07-30